Macular Atrophy in the Better‐Seeing Eye of Australian Patients Treated for Neovascular Age‐Related Macular Degeneration

Documenti analoghi

• Outcomes After Switching to Faricimab in Neovascular Age‐Related Macular Degeneration: Data From the Fight Retinal Blindness! Registry
  di: Adrian Hunt, et al.
  Pubblicazione: (2025)
• The Long Journey of Treatment for Wet Macular Degeneration, Is It Worth It?
  di: Mark Gillies
  Pubblicazione: (2025)
• Treat and Extend Anti‐VEGF Treatment Regimens for Neovascular Age‐Related Macular Degeneration: To Stop or Not to Stop?
  di: Praveen J. Patel
  Pubblicazione: (2025)
• Inherited Retinal Disease or Age‐Related Macular Degeneration: Predictive Value of Genetic Testing in Macular Disease With Atypical Atrophy
  di: Alexis Ceecee Britten‐Jones, et al.
  Pubblicazione: (2025)
• Progression of Loss of Vision From Centre‐Involving Macular Atrophy in Eyes Treated for nAMD
  di: Kelvin Y. C. Teo, et al.
  Pubblicazione: (2025)